University of colorado school of medicine, Medical school in Aurora, Colorado

Menstrual cycle patterns are generally used as an indicator to predict the onset of menopause in women. This approach, however, is severely inaccurate and can pinpoint the beginning of menopause only within a window spanning across four years.In a new study that has been published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism, researchers have developed a blood test that can forecast the commencement of menopause with relatively better accuracy.The study found that measuring levels of anti-Mullerian hormone (AMH) can predict when a woman's final menstrual period will occur. AMH serves as an indicator of how many eggs a woman has remaining. Women are born with their lifetime supply of eggs, and the supply decreases as women approach menopause."Establishing a way to measure time to the final menstrual period has long been the holy grail of menopause research," said co-lead author of the paper Nanette Santoro, M.D., of the University of Colorado Medical School in Aurora, Colorado."Using bleeding patterns or previously available tests to predict the time to menopause can only help us narrow the window to a four-year period, which is not clinically useful. Women can make better medical decisions with the more complete information offered by new, more sensitive anti-Mullerian hormone measurements."For women who are determining whether to have surgery to manage fibroids or whether it is safe to stop using birth control, having an AMH measurement can provide additional information about the timing of menopause, Santoro said. A low AMH level in a woman who is more than 48 years old indicates that menopause is likely approaching.A part of the Study of Women's Health Across the Nation (SWAN), this research analyzed blood tests conducted on 1,537 women between the ages of 42 and 63.The long-term SWAN study monitored changes in women's health as they went through the menopausal transition. For this study, participants' blood samples were tested for AMH levels as well as follicle-stimulating hormone, another reproductive hormone.Researchers used a more sensitive test than what has been available previously to measure the participants' AMH levels. This process made it possible to predict the final menstrual period's timing within 12 to 24 months in women in their late 40s and early 50s."Researchers have long thought AMH would be a superior marker of the time to menopause, but tests haven't been sensitive enough to detect the very, very low levels that occur in the year or two leading up to menopause," said co-lead author Joel S. Finkelstein of Massachusetts General Hospital in Boston, Mass."It took a cohort like the Study of Women's Health Across the Nation (SWAN), which followed the same women year after year from well before menopause until well after, to get the kind of data necessary to be able to demonstrate the predictive value of AMH."( With inputs from ANI )

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

Lok Sabha Election 2024

Heatwave In India

Mumbai Water Cut

Maharashtra Lok Sabha Election

IPL 2024

Salman Khan

University Of Colorado School Of MedicineFOLLOW

University of colorado school of medicine, Latest News

Health :Alzheimer's drug may also improve memory in down syndrome and normal ageing: Study

The results of the new study led by the University of Colorado Anschutz Campus have found that GM-CSF, which is an Alzheimer's drug, may improve cognitive function in people with Down syndrome. ...

International :Man questions bikini clad women at beach over their outfits, asks "Why do you dress this way?"

A group of women wearing bikinis at the beach were confronted by a man over their outfits. The man ... ...

Health :AstraZeneca monoclonal antibody therapy fails to prevent Covid symptoms

London, June 15 British-Swedish biopharmaceutical company AstraZeneca on Tuesday stated that its monoclonal antibody treatment failed to prevent ... ...

Technology :IVF success rates higher at clinics providing more information, says study

A recent study suggested that the success rates for in vitro fertilization at clinics increase upon receiving more information than required by government regulators. ...

Health :Screen COVID-19 patients for blood clotting abnormalities: Study

Saying that critically ill COVID-19 patients may be at high risk for developing renal failure, venous blood clots, and ... ...

Health :Blood test to predict menopause with better accuracy

Menstrual cycle patterns are generally used as an indicator to predict the onset of menopause in women. This approach, however, is severely inaccurate and can pinpoint the beginning of menopause only within a window spanning across four years. ...